Becker's Healthcare August 20, 2024
Former R1 RCM CEO Joe Flanagan will return to the role after two private equity firms complete their acquisition of the revenue cycle management company.
TowerBrook Capital Partners and Clayton, Dubilier & Rice are acquiring R1 RCM in a deal valued at $8.9 billion that is expected to close by the end of the year, subject to stockholder and regulatory approvals. The firms made the decision to reappoint Mr. Flanagan after the closure of the deal, according to an Aug. 8 regulatory filing.
The filing includes an email to employees from current R1 RCM CEO Lee Rivas, who said he is “supportive of this move as R1 approaches its...
Today's Sponsors
Today's Sponsor